Compliance or non-compliance during financial crisis: Does it matter?

被引:4
|
作者
Ahmad, Sardar [1 ]
Akbar, Saeed [2 ]
Kodwani, Devendra [3 ]
Halari, Anwar [3 ]
Shah, Syed Zubair [2 ]
机构
[1] Univ Liverpool, Management Sch, Chatham St, Liverpool L69 7ZH, Merseyside, England
[2] Univ Bradford, Sch Management, Bradford, W Yorkshire, England
[3] Open Univ, Business Sch, Milton Keynes, Bucks, England
关键词
financial crisis; financial firms; governance mechanism; internal controls; non‐ compliance; CORPORATE GOVERNANCE MECHANISMS; AGENCY COSTS; OWNERSHIP STRUCTURE; PANEL-DATA; EXECUTIVE-COMPENSATION; FIRM PERFORMANCE; MARKET VALUATION; UK; COMPANIES; IMPACT;
D O I
10.1002/ijfe.2538
中图分类号
F8 [财政、金融];
学科分类号
0202 ;
摘要
This paper investigates whether shareholder value is affected by non-compliance with the prescriptions of a principle-based 'comply or explain' system of corporate governance in the context of the global financial crisis of 2007-2009. Using System Generalized Method of Moments estimates to control for different types of endogeneity, the main findings of this paper suggest that non-compliance with the UK Corporate Governance Code adversely affects shareholder value. Furthermore, ex-post estimates reveal that compliance with certain corporate governance mechanisms is more beneficial than others. With regard to this, compliance with provisions related to board independence is more important than complying with performance-related pay requirements of the code. These findings have implications for policy makers and financial institutions regarding the usefulness of compliance with a prescribed code of corporate governance, specifically during periods of financial distress.
引用
收藏
页码:2348 / 2366
页数:19
相关论文
共 50 条
  • [1] NON-COMPLIANCE - DOES IT MATTER
    不详
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1979, 2 (6199): : 1168 - 1168
  • [2] NON-COMPLIANCE - DOES IT MATTER
    PASTOR, T
    [J]. BRITISH MEDICAL JOURNAL, 1979, 2 (6202): : 1437 - 1437
  • [3] NON-COMPLIANCE - DOES IT MATTER
    BANKS, DC
    [J]. BRITISH MEDICAL JOURNAL, 1979, 2 (6204): : 1585 - 1586
  • [4] Tamoxifen non-compliance: does it matter?
    Murthy, V
    Bharia, G
    Sarin, R
    [J]. LANCET ONCOLOGY, 2002, 3 (11): : 654 - 654
  • [5] Non-compliance
    Thuermann, P.
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2007, 101 (05) : 363 - 364
  • [6] NON-COMPLIANCE
    不详
    [J]. LANCET, 1983, 2 (8356): : 981 - 981
  • [7] Does short-term non-compliance predict long term non-compliance in ambulatory patients?
    Geers, Harm C. J.
    Egberts, Antoine A. C. G.
    Heerdink, Eibert E. R.
    Blaey de, Kees C. J.
    [J]. PHARMACY WORLD & SCIENCE, 2007, 29 (05): : 441 - 441
  • [8] Risk in sales, compliance and non-compliance
    Barba, Vincenzo
    [J]. REVISTA DE DERECHO CIVIL, 2024, 11 (02): : 291 - 301
  • [9] COMPLIANCE AND NON-COMPLIANCE IN YOUTH AND ADULTS
    MAGRI, F
    [J]. DEUTSCHE ZAHNARZTLICHE ZEITSCHRIFT, 1989, 44 (04): : 224 - &
  • [10] Cost of non-compliance
    Volmer, T
    Kielhorn, A
    [J]. GEBURTSHILFE UND FRAUENHEILKUNDE, 2000, 60 (06) : M82 - M85